Immunological and structural remodeling in human papillomavirus-induced warts and Bowen disease
- PMID: 23644544
- DOI: 10.1684/ejd.2013.1971
Immunological and structural remodeling in human papillomavirus-induced warts and Bowen disease
Abstract
Human papillomavirus-associated warts (HPV-warts) are persistent, evading host immune surveillance. However, these warts sometimes disappear spontaneously, following inflammation. Non-inflamed HPV-warts demonstrated decreased numbers of epidermal Langerhans cells (LCs), low expression levels of MIP3α and E-cadherin, and no apoptotic cells. In the inflamed HPV-warts, on the other hand, various dendritic cell (DC) subsets and many CD8+ cytotoxic T lymphocytes (CTLs) were recruited in association with epidermal MIP3α expression. Many apoptotic keratinocytes were observed in the dermo-epidermal junction. Cellular events were different in HPV-induced Bowen disease (HPV-Bowen): a few LCs were retained in the lesional epidermis, and considerable numbers of B-cells and plasma cells were also observed in the infiltrates, with little or no infiltration of plasmacytoid DCs or dermal/mature DCs. Multiple HPV16-Bowen diseases in the same individuals showed the presence of different sizes of E6/E7-containing cellular transcripts, which indicated that HPV genomes were integrated into the different sites of chromosomes. Toll-like receptor (TLR) 3 was expressed by the lesional keratinocytes even in the non-inflamed HPV-warts, and type 1 interferons (IFNs) were produced in cultured keratinocytes by TLR3 stimulation. HPV-warts are protected from host immune responses and apoptotic signals because they are surrounded by LC-depleted epidermal walls, and viral anti-apoptotic molecules. The up-regulation of epidermal TLR3 signaling might inhibit further HPV spreading.
Keywords: Bowen disease; dendritic cell; human papillomavirus; toll-like receptor.
Similar articles
-
Dendritic cell subsets and immunological milieu in inflammatory human papilloma virus-related skin lesions.J Dermatol Sci. 2011 Sep;63(3):173-83. doi: 10.1016/j.jdermsci.2011.05.006. Epub 2011 Jun 6. J Dermatol Sci. 2011. PMID: 21715145
-
Type 2 human papillomavirus E7 attenuates E-cadherin expression in human keratinocytes.J Microbiol. 2021 Jun;59(6):616-625. doi: 10.1007/s12275-021-0690-y. Epub 2021 Mar 29. J Microbiol. 2021. PMID: 33779957
-
Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.J Virol. 2009 Jul;83(13):6779-89. doi: 10.1128/JVI.02443-08. Epub 2009 Apr 22. J Virol. 2009. PMID: 19386711 Free PMC article.
-
Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.J Infect Chemother. 2012 Dec;18(6):807-15. doi: 10.1007/s10156-012-0485-5. Epub 2012 Nov 3. J Infect Chemother. 2012. PMID: 23117294 Review.
-
Epithelial cell responses to infection with human papillomavirus.Clin Microbiol Rev. 2012 Apr;25(2):215-22. doi: 10.1128/CMR.05028-11. Clin Microbiol Rev. 2012. PMID: 22491770 Free PMC article. Review.
Cited by
-
The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.Oncoimmunology. 2014 Jan 1;3(1):e28288. doi: 10.4161/onci.28288. Epub 2014 Apr 15. Oncoimmunology. 2014. PMID: 24800179 Free PMC article.
LinkOut - more resources
Full Text Sources
Research Materials